Literature DB >> 30898943

Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus.

Kalliopi Azariadis1, Nikolaos K Gatselis1,2, George K Koukoulis3, Georgios N Dalekos1,2.   

Abstract

Glycogenic hepatopathy (GH) is a rare complication of poorly controlled type 1 diabetes mellitus (T1DM). We present a 19-year-old woman with T1DM and autoimmune thyroiditis who admitted to our department because of abrupt onset intermittent abdominal pain in the right upper quadrant accompanied by laboratory evidence of acute anicteric hepatitis. Physical examination revealed significant hepatomegaly but the common imagining studies were negative. Following exclusion of common causes of acute hepatitis and because of the presence of smooth muscle antibodies in a young female patient with already established two autoimmune diseases, a liver biopsy was performed in order to exclude the potential presence of autoimmune hepatitis. However, liver histology showed typical findings of GH. Intense treatment targeting strict glycemic control resulted in normalisation of liver biochemistry. This case underlines that GH should be considered as a rare cause of acute hepatitis in T1DM patients with poor glycemic control. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  diabetes; hepatitis other; metabolic disorders; pathology

Mesh:

Substances:

Year:  2019        PMID: 30898943      PMCID: PMC6453433          DOI: 10.1136/bcr-2018-228524

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  47 in total

1.  Hepatic glycogenosis: abnormal liver function tests in Type 1 diabetes.

Authors:  D J Cuthbertson; G Brennan; S Walsh; E Henry
Journal:  Diabet Med       Date:  2007-03       Impact factor: 4.359

2.  Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus.

Authors:  Michael Torbenson; Yunn-Yi Chen; Elizabeth Brunt; Oscar W Cummings; Marcia Gottfried; Shriram Jakate; Yao-Chang Liu; Matthew M Yeh; Linda Ferrell
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

Review 3.  Glycogenic hepatopathy.

Authors:  Johad Khoury; Yaniv Zohar; Naim Shehadeh; Tarek Saadi
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2018-02-19

Review 4.  Diabetes Association with Liver Diseases: An Overview for Clinicians.

Authors:  Abd Elkhalek Hamed; Nadia Elwan; Mervat Naguib; Reda Elwakil; Gamal Esmat; Mohamed El Kassas; Sherief Abd-Elsalam; Shorouk Moussa
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2019       Impact factor: 2.895

5.  GLYCOGENIC HEPATOPATHY: A COMPLICATION OF UNCONTROLLED DIABETES.

Authors:  Medha Satyarengga; Yelena Zubatov; Sylvaine Frances; Gopal Narayanswami; Rodolfo J Galindo
Journal:  AACE Clin Case Rep       Date:  2017

Review 6.  Computed Tomography and Magnetic Resonance Imaging Features of Primary and Secondary Hepatic Glycogenosis.

Authors:  Zhi-Yuan Chen; Yu-Pin Liu; Guang-Juan Zheng
Journal:  Ann Hepatol       Date:  2018-10-16       Impact factor: 2.400

7.  Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.

Authors:  G N. Dalekos; K Zachou; C Liaskos; N Gatselis
Journal:  Eur J Intern Med       Date:  2002-08       Impact factor: 4.487

8.  Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study.

Authors:  J H Hwang; G Perseghin; D L Rothman; G W Cline; I Magnusson; K F Petersen; G I Shulman
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

9.  Glycogenic hepatopathy, an underdiagnosed cause of relapsing hepatitis in uncontrolled type 1 diabetes mellitus.

Authors:  Ahmed A Al Sarkhy; Zafar A Zaidi; Amir M Babiker
Journal:  Saudi Med J       Date:  2017-01       Impact factor: 1.484

10.  An Unusual Presentation of Glycogenic Hepatopathy with Bridging Fibrosis.

Authors:  Jagannath M Sherigar; Yoness Darouichi; Debra Guss; Smruti R Mohanty
Journal:  ACG Case Rep J       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.